← All research updates

A study testing the drug VRT106 in people whose glioblastoma has come back

Original title: A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

How far along is this research?

This is a trial that is enrolling or has been updated. It is not a finding yet.

This is an early test in people, so safety is still being checked.

Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.

The trial team last updated this record on . Always check the trial page for the latest.

The short version

This trial is testing a drug called VRT106 in people whose glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary has returned or is growing.

Who this trial is for. This trial is for people with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary that has come back or is growing. It tests a drug called VRT106. Everyone in the study gets the same drug, and everyone knows what they are getting.

Where it stands. This trial has not reported results. The team is checking how safe the drug is and how well people handle it. They are also looking at whether it helps. Those answers are not in yet.

What this means, and what it doesn't

What it could mean: Nothing about this drug is settled yet. Someone whose glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary has come back could ask their care team about this study. The care team can say if it makes sense to look into.

What it doesn't mean: This does not mean VRT106 works. A trial is a test, not a proven treatment. Being in one is not a promise of any benefit. It is not a cure.

Source: ClinicalTrials.gov, October 29, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary